Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in radiotherapy for soft-tissue sarcoma.

Brian O'Sullivan1, Iain Ward, Charles Catton

  • 1Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada. brian.osullivan@rmp.uhn.on.ca

Current Oncology Reports
|June 5, 2003
PubMed
Summary

Radiotherapy in soft-tissue sarcoma management is evolving. Recent studies identify patients who can forgo radiotherapy, optimizing treatment and function while exploring new delivery strategies for improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same author

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change.

International journal of cancer·2026
Same author

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Oral oncology·2026
Same author

Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

ASO Visual Abstract: Key Updates on the Version 9 AJCC/UICC Staging System for Salivary Gland Carcinoma.

Annals of surgical oncology·2026
Same author

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

Head & neck·2026

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Radiotherapy is a cornerstone in soft-tissue sarcoma management, but its role is continually refined.
  • Recent clinical studies and publications are reshaping current treatment paradigms.

Purpose of the Study:

  • To review the evolving role of radiotherapy in soft-tissue sarcoma management.
  • To identify patient subsets who may not require radiotherapy for cure and good function.
  • To discuss advancements in radiotherapy delivery strategies and their impact.

Main Methods:

  • Review of recent publications and prospective trial data, including randomized trials.
  • Analysis of surgical excision adequacy and local control with positive margins.
  • Discussion of chemoradiotherapy protocols and advanced radiotherapy techniques.

Related Experiment Videos

Main Results:

  • Identification of a patient subset who can achieve sarcoma cure and good function without radiotherapy.
  • Evaluation of preoperative versus postoperative radiotherapy based on prospective and randomized data.
  • Integration of surgical margins and local control strategies into treatment planning.

Conclusions:

  • Current evidence allows for the establishment of guidelines to select patients who can avoid radiotherapy.
  • Advanced radiotherapy techniques, including image-guided approaches, offer potential for improved outcomes.
  • Chemoradiotherapy protocols may enhance both local and systemic control for specific sarcoma types, such as retroperitoneal sarcomas.